Law360
10 Global Challenges For Life Sciences Cos. In 2016
January 27, 2016
Life sciences companies face many challenges for 2016, including the demand to develop innovative products at reduced cost. More and more, this means that companies must assess opportunities in major markets across the globe and seek value-maximizing partnerships at all phases of the product life cycle, from development to manufacturing to marketing. The increasingly global and increasingly interconnected nature of the life sciences industry also means that companies must track litigation, policy, regulatory and enforcement developments in the U.S., EU, Asia and other major markets, and must also anticipate the ways in which these developments will impact business opportunities.
Contacts

Capabilities
Suggested News & Insights
U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 12, 2025BIOSECURE Act Included in the FY2026 National Defense Authorization ActDecember 12, 2025Sidley Represents Immunovant in US$550 Million OfferingDecember 12, 2025Sidley Ranked in Chambers Asia-Pacific 2026December 11, 2025U.S. Drug Pricing Year in Review: Reflections on 2025 and Getting Ready for 2026December 11, 2025What the U.S.–UK Drug Pricing Agreement Reveals About How MFN Drug Policy Could Impact the UK and EUDecember 10, 2025
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory

